Furthermore, the thresholds of ALT values accepted previously may underdiagnose liver disease.[37] Recognizing the clinical limitation of ALT, the SAFETY study, using data from the National Health and Nutrition Examination Survey, was conducted. The gene discussed is GPT; the disease is liver disorder.